TOLAZAMIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for tolazamide and what is the scope of patent protection?

Tolazamide is the generic ingredient in two branded drugs marketed by Barr, Chartwell Rx, Cosette, Duramed Pharms Barr, Interpharm, Natco, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Watson Labs, and Pharmacia And Upjohn, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for tolazamide.

Summary for TOLAZAMIDE

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	31
Drug Master File Entries:	6
Raw Ingredient (Bulk) Api Vendors:	73
Clinical Trials:	3
Patent Applications:	6,973
DailyMed Link:	TOLAZAMIDE at DailyMed

Recent Clinical Trials for TOLAZAMIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Canadian Institutes of Health Research (CIHR)
Canadian Network for Observational Drug Effect Studies, CNODES
Drug Safety and Effectiveness Network, Canada

See all TOLAZAMIDE clinical trials

Medical Subject Heading (MeSH) Categories for TOLAZAMIDE

Hypoglycemic Agents

Anatomical Therapeutic Chemical (ATC) Classes for TOLAZAMIDE

A10BB	Sulfonylureas
A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10	DRUGS USED IN DIABETES
A	Alimentary tract and metabolism

US Patents and Regulatory Information for TOLAZAMIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Usl Pharma	TOLAZAMIDE	tolazamide	TABLET;ORAL	070169-001	Apr 2, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Industries	TOLAZAMIDE	tolazamide	TABLET;ORAL	071357-001	Jul 16, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cosette	TOLAZAMIDE	tolazamide	TABLET;ORAL	018894-001	Nov 2, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.